Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction

Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction

Bibliographic Details
Main Authors:	Wei Yongjun, Xiao Ping, Wu Benjuan, Chen Fuxi, Shi Xiaofeng
Format:	Article
Language:	English
Published:	De Gruyter 2023-08-01
Series:	Open Life Sciences
Subjects:	diagnosis sepsis biomarker soluble triggering receptor expressed on myeloid cells-1 soluble suppression of tumorigenicity 2
Online Access:	https://doi.org/10.1515/biol-2022-0639

Similar Items

sTREM-1 predicts mortality in hospitalized patients with infection in a tropical, middle-income country
by: Shelton W. Wright, et al.
Published: (2020-07-01)

Diagnostic value of serum soluble triggering expressed receptor on myeloid cells 1 (sTREM-1) in suspected sepsis: a meta-analysis
by: Wei Chang, et al.
Published: (2020-01-01)

Diagnostic value of combined detection of serum levels of HMGB1 and sTREM-1 in sepsis complicated with acute kidney injury
by: Lin-lin Sun, et al.
Published: (2024-03-01)

Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis
by: Federica Azzolini, et al.
Published: (2022-01-01)

Significance of sTREM-1 in early prediction of ventilator-associated pneumonia in neonates: a single-center, prospective, observational study
by: Xingxing Zhao, et al.
Published: (2020-07-01)

Serum sTREM2: A Potential Biomarker for Mild Cognitive Impairment in Patients With Obstructive Sleep Apnea
by: Xu Jiahuan, et al.
Published: (2022-05-01)

Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study
by: Su Longxiang, et al.
Published: (2012-07-01)

Soluble Suppression of Tumorigenicity 2 is Directly Correlated with Glycated Hemoglobin in Individuals with an Average glycemia in the Normal/Prediabetes Range
by: Hasan A, et al.
Published: (2020-08-01)

Soluble Suppression of Tumorigenicity 2 (sST2) in Patients with Predominantly Decompensated Right Heart Failure—A Prospective Observational Study
by: Victoria Dworok, et al.
Published: (2023-11-01)

Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis
by: Christina Ip, et al.
Published: (2021-12-01)

Predictive Value of GDF-15 and sST2 for Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: Lv Z, et al.
Published: (2023-11-01)

Increased CSF Soluble TREM2 Concentration in Patients With Neurosyphilis
by: Wurong Li, et al.
Published: (2020-02-01)

The Diagnostic Value of Soluble ST2 in Heart Failure: A Meta-Analysis
by: Chaojun Yang, et al.
Published: (2021-07-01)

Values of PCT and STREM-1 combined with clinical pulmonary infection score for the prognostic evaluation of elderly patients with ventilator-associated pneumonia
by: Wang Jianjun, et al.
Published: (2022-01-01)

The role of TREM2 in Alzheimer’s disease: from the perspective of Tau
by: Wendi Huang, et al.
Published: (2023-11-01)

Performance Evaluation of AFIAS ST2 and Ichroma ST2 Assays in Comparison with Presage ST2 Assay
by: Hanah Kim, et al.
Published: (2023-03-01)

Synergistic Effects of Weighted Genetic Risk Scores and Resistin and sST2 Levels on the Prognostication of Long-Term Outcomes in Patients with Coronary Artery Disease
by: Hsin-Hua Chou, et al.
Published: (2022-04-01)

Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes
by: Jagan A. Pillai, et al.
Published: (2021-06-01)

Predictive value of soluble suppression of tumorigenicity 2 in atrial fibrillation: a systematic review and meta-analysis
by: Pengfei Chen, et al.
Published: (2024-01-01)

Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
by: Dong-Hui Huang, et al.
Published: (2016-01-01)

The Diagnostic Value of Soluble Triggering Receptor Expressed on Myeloid Cells for Patients with Acute Stone Pyelonephritis
by: Metin Özsoy, et al.
Published: (2024-04-01)

sST2 Level at Decompensated Chronic Heart Failure in Patients with Dilated Cardiomyopathy
by: Khumoyun A. Gulomov, et al.
Published: (2022-06-01)

Soluble suppression of tumorigenicity 2 associated with atrial fibrillation detected after stroke: A retrospective study
by: Wenquan Hou, et al.
Published: (2023-11-01)

sTREM-1 and TNF-α levels are associated with the clinical outcome of leprosy patients
by: Márcio Bezerra-Santos, et al.
Published: (2023-06-01)

Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation
by: Javier García-Seara, et al.
Published: (2023-09-01)

Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
by: Elke Boxhammer, et al.
Published: (2022-03-01)

Predictive value of sST2 level in immune-related adverse events
by: XU Yuchen, CHENG Leilei, WANG Yan, LIN Jinyi, CHEN Jiahui, CHEN Yifan, ZHOU Yuhong, LIU Tianshu, GE Junbo
Published: (2022-08-01)

Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients
by: Nasr El-Din A, et al.
Published: (2021-08-01)

The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI Cohort
by: Qixiong Qin, et al.
Published: (2022-06-01)

A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease
by: Trine Holt Edwin, et al.
Published: (2020-01-01)

The soluble suppression of tumorigenicity 2 as a biomarker of early cardiac remodeling in bradycardia patients receiving permanent pacemaker therapy
by: Mohammad Iqbal, et al.
Published: (2023-01-01)

Superior prognostic value of soluble suppression of tumorigenicity 2 for the short-term mortality of maintenance hemodialysis patients compared with NT-proBNP: a prospective cohort study
by: Zhiyu Wang, et al.
Published: (2020-01-01)

CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
by: Kristi Henjum, et al.
Published: (2018-11-01)

Severe Periodontitis and Biomarkers of Bacterial Burden. Results From a Case-Control and Intervention Clinical Trial
by: Yago Leira, et al.
Published: (2021-03-01)

Evaluation of serum interleukin-33 and soluble suppression of tumorigenicity 2 (sST2) receptors in patients with and without periodontal disease
by: Himadri Singh, et al.
Published: (2022-01-01)

Soluble myeloid triggering receptor expressed on myeloid cell 1 might have more diagnostic value for bacterial ascites than C-reactive protein
by: Guo Qiang, et al.
Published: (2018-12-01)

Effects of budesonide combined with noninvasive ventilation on PCT, sTREM-1, chest lung compliance, humoral immune function and quality of life in patients with AECOPD complicated with type II respiratory failure
by: Gao Erxiang, et al.
Published: (2019-03-01)

Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Inflammatory Markers in Colorectal Cancer Surgery: A Prospective Cohort Study
by: Lovorka Ðerek, et al.
Published: (2017-01-01)

Diagnostic
by: Alaa Refaat, et al.
Published: (2014-07-01)

TREM2 ectodomain and its soluble form in Alzheimer’s disease
by: Jiaolong Yang, et al.
Published: (2020-07-01)